High-flow nasal cannula therapy for acute respiratory failure in patients with interstitial pneumonia: a retrospective observational study

ABSTRACT High-flow nasal cannula (HFNC) oxygen is a therapy that has demonstrated survival benefits in acute respiratory failure (ARF). However, the role of HFNC in ARF due to interstitial pneumonia (IP) is unknown. The aim of this study was to compare the effects of HFNC therapy and non-invasive positive pressure ventilation (NPPV) in ARF due to IP. This retrospective observational study included 32 patients with ARF due to IP who were treated with HFNC (n = 13) or NPPV (n = 19). The clinical characteristics, intubation rate and 30-day mortality were analyzed and compared between the HFNC group and the NPPV group. Predictors of 30-day mortality were evaluated using a logistic regression model. HFNC group showed higher mean arterial blood pressure (median 92 mmHg; HFNC group vs 74 mmHg; NPPV group) and lower APACHEII score (median 22; HFNC group vs 27; NPPV group) than NPPV group. There was no significant difference in the intubation rate at day 30 between the HFNC group and the NPPV group (8% vs 37%: p = 0.069); the mortality rate at 30 days was 23% and 63%, respectively. HFNC therapy was a significant determinant of 30-day mortality in univariate analysis, and was confirmed to be an independent significant determinant of 30-day mortality in multivariate analysis (odds ratio, 0.148; 95% confidence interval, 0.025–0.880; p = 0.036). Our findings suggest that HFNC therapy can be a possible option for respiratory management in ARF due to IP. The results observed here warrant further investigation of HFNC therapy in randomized control trials.

[1]  Arthur S Slutsky,et al.  Not Just Oxygen? Mechanisms of Benefit from High-Flow Nasal Cannula in Hypoxemic Respiratory Failure. , 2017, American journal of respiratory and critical care medicine.

[2]  Jin Liu,et al.  Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: a meta-analysis of randomized controlled trials , 2017, Canadian Medical Association Journal.

[3]  D. Baidya,et al.  Comparison of high-flow nasal oxygen therapy with conventional oxygen therapy and noninvasive ventilation in adult patients with acute hypoxemic respiratory failure: A meta-analysis and systematic review. , 2016, Journal of critical care.

[4]  H. Ueoka,et al.  Survival from acute exacerbation of idiopathic pulmonary fibrosis with or without direct hemoperfusion with polymyxin B-immobilized fiber column: A retrospective analysis , 2016 .

[5]  M. Nishimura.  High-Flow Nasal Cannula Oxygen Therapy in Adults: Physiological Benefits, Indication, Clinical Benefits, and Adverse Effects , 2016, Respiratory Care.

[6]  S. Sakao,et al.  Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study , 2015, Drug design, development and therapy.

[7]  L. Brochard,et al.  High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. , 2015, The New England journal of medicine.

[8]  S. Ragot,et al.  Sequential Application of Oxygen Therapy Via High-Flow Nasal Cannula and Noninvasive Ventilation in Acute Respiratory Failure: An Observational Pilot Study , 2015, Respiratory Care.

[9]  R. Scala,et al.  Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases , 2014, BMC Pulmonary Medicine.

[10]  T. Kishaba,et al.  Staging of Acute Exacerbation in Patients with Idiopathic Pulmonary Fibrosis , 2014, Lung.

[11]  S. Jaber,et al.  Comparison of three high flow oxygen therapy delivery devices: a clinical physiological cross-over study. , 2013, Minerva anestesiologica.

[12]  C. Kıraklı,et al.  Why Do Patients With Interstitial Lung Diseases Fail in the ICU? A 2-Center Cohort Study , 2013, Respiratory Care.

[13]  S. Nanjo,et al.  Clinical Features and Outcome of Acute Exacerbation of Interstitial Pneumonia: Collagen Vascular Diseases-Related versus Idiopathic , 2011, Respiration.

[14]  S. McGuinness,et al.  The Effects of Flow on Airway Pressure During Nasal High-Flow Oxygen Therapy , 2011, Respiratory Care.

[15]  Jong-Min Song,et al.  Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome , 2010, European Respiratory Journal.

[16]  T. Shaffer,et al.  Research in high flow therapy: mechanisms of action. , 2009, Respiratory medicine.

[17]  T. Colby,et al.  Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases , 2009, Respiratory Medicine.

[18]  K. Brown,et al.  Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series. , 2008, Chest.

[19]  S. Mallick.  Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit. , 2008, Respiratory medicine.

[20]  O. Gajic,et al.  Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease. , 2008, Chest.

[21]  N. Müller,et al.  Acute Exacerbation of Chronic Interstitial Pneumonia: High-resolution Computed Tomography and Pathologic Findings , 2007, Journal of thoracic imaging.

[22]  T. Shim,et al.  Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. , 2007, Chest.

[23]  N. Müller,et al.  Acute Exacerbation (Acute Lung Injury of Unknown Cause) in UIP and Other Forms of Fibrotic Interstitial Pneumonias , 2007, The American journal of surgical pathology.

[24]  L. Domínguez,et al.  [Cohort study on incidence of ARDS in patients admitted to the ICU and prognostic factors of mortality]. , 2006, Medicina intensiva.

[25]  M. Kitaichi,et al.  Chronic bird fancier’s lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias , 2005, Thorax.

[26]  P. Foucher,et al.  Interstitial Lung Disease Induced by Drugs and Radiation , 2004, Respiration.

[27]  M. Antonelli,et al.  Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study , 2001, Intensive Care Medicine.

[28]  F Lemaire,et al.  Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivered by a face mask: A randomized controlled trial. , 2000, JAMA.

[29]  J. Smolen,et al.  Mixed connective tissue disease: to be or not to be? , 1998, Arthritis and rheumatism.

[30]  Y. Kawabata,et al.  Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. , 1993, Chest.

[31]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[32]  N. Jones,et al.  Pattern of breathing during exercise in patients with interstitial lung disease. , 1983, Thorax.

[33]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[34]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[35]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975 .

[36]  H. Mal,et al.  Invasive mechanical ventilation in patients with fibrosing interstitial pneumonia. , 2014, The Journal of thoracic and cardiovascular surgery.

[37]  K. Kubo,et al.  Noninvasive ventilation in acute exacerbation of idiopathic pulmonary fibrosis. , 2010, Internal medicine.